iBio (IBIO) Institutional Ownership $3.48 -0.15 (-4.13%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$3.56 +0.08 (+2.30%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for iBio (NYSE:IBIO)CurrentInstitutional OwnershipPercentage7.90%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$7.70MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$906.47K Get IBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling iBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IBIO Institutional Buying and Selling by Quarter iBio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 ADAR1 Capital Management LLC415,606$1.02M0.2%-12.7%4.228% 2/12/2025 Geode Capital Management LLC83,797$205K0.0%+52.3%0.852% 8/15/2024 Lynx1 Capital Management LP240,763$508K0.2%-59.9%2.792% 5/30/2024 Lynx1 Capital Management LP600,000$2.44M0.6%N/A6.957% 5/29/2024 Opaleye Management Inc.680,000$2.76M0.6%N/A7.889% 5/17/2024 Ikarian Capital LLC600,000$2.44M0.3%N/A6.961% (Data available from 1/1/2016 forward) IBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IBIO shares? During the previous two years, the following institutional investors and hedge funds held shares of iBio shares: Opaleye Management Inc. ($2.76M), Ikarian Capital LLC ($2.44M), ADAR1 Capital Management LLC ($1.02M), and Lynx1 Capital Management LP ($508K), Geode Capital Management LLC ($205K).Learn more on IBIO's institutional investors. What percentage of iBio stock is owned by institutional investors? 7.90% of iBio stock is owned by institutional investors. Learn more on IBIO's institutional investor holdings. Which institutional investors have been buying iBio stock? The following institutional investors have purchased iBio stock in the last 24 months: Opaleye Management Inc. ($680K), Ikarian Capital LLC ($600K), Lynx1 Capital Management LP ($600K), and Geode Capital Management LLC ($28.78K). How much institutional buying is happening at iBio? Institutional investors have bought a total of 1,908,775 shares in the last 24 months. This purchase volume represents approximately $7.70M in transactions. Which iBio major shareholders have been selling company stock? The following institutional investors have sold iBio stock in the last 24 months: Lynx1 Capital Management LP ($359.24K), and ADAR1 Capital Management LLC ($60.61K). How much institutional selling is happening at iBio? Institutional investors have sold a total of 419,843 shares in the last 24 months. This volume of shares sold represents approximately $906.47K in transactions. Related Companies BDTX Major Shareholders CABA Major Shareholders TSVT Major Shareholders KYTX Major Shareholders SGMT Major Shareholders IVA Major Shareholders RENB Major Shareholders TELO Major Shareholders CRBU Major Shareholders IZTC Major Shareholders This page (NYSE:IBIO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
